Bovogen Biologicals Ultra Low IgG FBS

Sunday, 01 December, 2019 | Supplied by: Scientifix Pty Ltd


Bovogen Biologicals’ foetal bovine serum (NZ origin) is manufactured in a fully validated sterile filtration facility, following strict GMP process, and is fully traceable. The FBS manufacturing process follows a strict quality controlled protocol.

All batches of FBS are triple 0.1 μm sterile filtered in a validated aseptic sterile filtration suite using a fully disposable closed loop filtration train. The closed-loop filtration system is fully disposable to ensure that all product contact parts are only used once, minimising any risk of contamination or human error.

The company’s latest product release is the Bovogen Ultra Low IgG FBS. Using a proprietary chromatographic process, IgG has been removed from the FBS with the ultimate goal of retaining the serum’s cellular viability and biological growth promoting activity. The IgG level in the UL IgG FBs is <0.5 ug/mL. Specific applications include monoclonal antibody research and production or where extremely low levels of IgG are required for cell culture and protein purification applications.

The product is manufactured by Bovogen Biologicals in 100 and 500 mL bottles, and distributed exclusively in Australia by Scientifix and Scientific Partners (WA).

Phone: 03 8540 5900
Related Products

BioVision ToxOut Protein A (Sepharose) and Protein G (Sepharose) Antibody Purification Kits

BioVision's ToxOut Protein A (Sepharose) and ToxOut Protein G (Sepharose) Antibody...

Bio-Rad Laboratories EveryBlot Blocking Buffer

Bio-Rad Laboratories has launch of the EveryBlot Blocking Buffer — a western blot blocking...

Merck Sucrose EMPROVE EXPERT Ph Eur, ChP, JP, NF

Merck has developed a filtration-based manufacturing process resulting in a highly purified...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd